Ipilimumab
IRB00104273
Phase 1 mab active
Quick answer
Ipilimumab for Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 is a Phase 1 program (mab) at VACCINEX, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VACCINEX, INC.
- Indication
- Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
- Phase
- Phase 1
- Modality
- mab
- Status
- active